GlassScriptPhysician profile
Nancy K Coates
NPI 1982009056
$819.51
in general payments reported to CMS, 2019-2025
12 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $165 · 2022: $147 · 2023: $217 · 2024: $136 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Indivior INC. | $192.12 | 2021-2025 | Sublocade |
| Braeburn INC. | $188.64 | 2023-2025 | Brixadi |
| Abbvie INC. | $114.51 | 2022-2025 | |
| Uswm, LLC | $60.93 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.27 | 2021 | |
| Gilead Sciences, INC. | $47.55 | 2021-2023 | |
| Boston Scientific Corporation | $42.57 | 2022-2025 | General - Pain Management |
| Atricure, INC. | $41.64 | 2023 | |
| Collegium Pharmaceutical, INC. | $27.83 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $21.46 | 2023 | Imbruvica |
| Almatica Pharma LLC | $17.56 | 2021 | |
| Biodelivery Sciences International, INC. | $13.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Coates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.